Alcohol consumption was traditionally high in Mediterranean countries, particularly in France and Italy, but substantial declines have been observed over the last four decades. Material and methods: We obtained official resident population and death certification data from the World Health Organization (WHO) database for 5 major alcohol-related cancer sites in Italy for the 1970-2017 period. We computed age-standardised (world population) mortality rates and applied a joinpoint model to identify changes in trends. Yearly pure alcohol per capita consumption data (total, beer, spirits and wine) for Italy over the 1961-2018 period were obtained from the WHO European Health for All database. Results: Since the late 1970's, alcohol consumption has been declining substantially in Italy, from about 20 to 7 litres of ethanol per adult per day. In men upper-respiratory tract cancer mortality fell consistently over the last decade, oral cavity and pharyngeal cancer by 14% to 3.1/100,000 men and 2,103 deaths; oesophageal cancer by 13% to 2.0/100,000 and 1,409 deaths, and laryngeal cancer by 27% to 1.8/100,000 men and 1,428 deaths in 2017. Liver cancer had a rate of 4.9/100,000 men (3,667 deaths) in 2017. Conclusions: This decline in alcohol consumption led to substantial declines in cirrhosis and other chronic liver diseases including liver cancer, and in all major alcohol related cancers (oral cavity and pharynx, oesophagus, larynx, liver, and also breast) in the last few decades in Italy. However, the favourable trends in alcohol-related mortality in Italy and other Mediterranean countries are not reflected in Central-Northern Europe and the USA. Thus, alcohol remains a major cause of cancer and other diseases in Europe.
Miscarriages account for about one in six/one in seven pregnancies, and probably over one in five excluding induced abortions, i.e. over 20 million events per year. However, any precise and valid estimate is made difficult by uncertainties in diagnosis, ascertainment, distinction in registration between induced and spontaneous abortions, and certification. These uncertainties vary across geographic region, country and socio-economic status...
Tomatoes have been estimated as the second most important source of vitamin C, after oranges, in an Italian population. We have therefore considered the relationship between tomato intake and the risk of digestive tract cancers using data from a series of case-control studies conducted in Italy between 1983 and 1992, and including 317 histologically confirmed, incident cases of cancer of the oral cavity and pharynx, 85 of the esophagus, 723 of the stomach, 955 of the colon, and 629 of the rectum, and a total of 2879 controls admitted for acute, non-neoplastic conditions, unrelated to long-term modifications of diet. Multivariate odds ratios (OR) and 95% confidence intervals (CI) for subsequent quartiles of intake of tomatoes were derived, after allowance for age, sex, study center, education, smoking, alcohol drinking, and total calorie intake. There was a consistent pattern of protection for all sites. The ORs for the highest consumption quartile were 0.65 (95% CI 0.4-1.0) for oral cavity, pharynx, and esophagus, 0.43 (95% CI 0.3-0.6) for stomach, 0.39 (95% CI 0.3-0.5) for colon, and 0.42 (95% CI 0.3-0.6) for rectum. Another study of colorectal cancer, based on 1,953 cases and 4,154 controls, conducted between 1992 and 1996 and using a more detailed food frequency questionnaire, confirmed that tomato intake was significantly protective on colorectal cancer risk, even after allowance for several potential confounding factors, including measures of body mass index, calorie intake, and physical activity. The ORs for the highest consumption quintile were 0.79 (95% CI 0.6-0.9) for colon, and 0.71 (95% CI 0.5-0.9) for rectal cancer. The beneficial effect of tomatoes observed in these epidemiological studies may be due to the fact that they constitute one of the most specific features of the Mediterranean diet. This has both a scientific and a public health relevance.
We identify the interfollicular (IF) zone as the site where germinal center B cell and T follicular helper (Tfh) cell differentiation initiates. For the first 2 days postimmunization, antigen-specific T and B cells remained confined within the IF zone, formed long-lived interactions, and upregulated the transcriptional repressor Bcl6. T cells also acquired the Tfh cell markers CXCR5, PD-1, and GL7. Responding B and T cells migrated to the follicle interior directly from the IF zone, T cell immigration preceding B cells by 1 day. Notably, in the absence of cognate B cells, Tfh cells still formed and migrated to the follicle. However, without such B cells, PD-1, ICOS, and GL7 were no longer expressed on follicular Bcl6(hi) T cells that nevertheless persisted in the follicle. Thus, Ag-specific B cells are required for the maintenance of the PD-1(hi)ICOS(hi)GL7(hi) Tfh cell phenotype within the follicle, but not for their initial differentiation in the IF zone.Copyright © 2011 Elsevier Inc. All rights reserved. PMID: 21636295 Funding information This work was supported by: NIAMS NIH HHS, United States Grant ID: P30AR053495 NIAID NIH HHS, United States Grant ID: R01AI080850 Canadian Institutes of Health Research, Canada NIAMS NIH HHS, United States Grant ID: P30 AR053495 NIAID NIH HHS, United States Grant ID: R01 AI080850 NIAID NIH HHS, United States Grant ID: R01 AI080850-01A1 More Less keyboard_arrow_down